All Of Us is a research program from the National Institutes of Health (NIH). It is seeking 1 million or more people from across the US. By doing so, it hopes to one day help speed up medical research.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world.
If you or someone you love has been diagnosed with pancreatic cancer, we are here to help. We provide more resources and speak with more pancreatic cancer patients and caregivers than any other organization in the world. No one should have to face pancreatic cancer alone.
University of Minnesota's Study Finder is a tool to help people find studies to participate in that can help create a healthier future.
Black Americans have at least double the incidence of myeloma as any other race or ethnicity, and recent studies show they face additional barriers and lower access to care.
As Vice President, in 2016, Joe Biden launched the Cancer Moonshot with the mission to accelerate the rate of progress against cancer. The cancer and patient community and medical researchers responded with tremendous energy and ingenuity.
February 22, 2022
Equity, Diversity and Inclusion at ASCO.
Providing access to genetic counseling, testing, related cancer screening and preventive services for Medicare beneficiaries with a personal or family history of hereditary cancer.
This infographic helps healthcare professionals to understand the Social Determinants of Health (SDOH) Z codes.
New analysis based on IQVIA data finds that certain demographics and social determinants are associated with an increased likelihood of patients with commercial insurance abandoning their prescribed medicines.
"ALL PATIENTS, NO MATTER WHO THEY ARE OR WHERE THEY LIVE, DESERVE THE HIGHEST QUALITY CANCER CARE."
April 6, 2022
On March 30, clinical trial leaders, hospital practitioners and patient representatives met in the latest installment of the Diversity in Oncology series hosted by GRYT Health and Bristol Myers Squibb. The purpose: to uncover barriers to clinical trial access and work toward actionable structural improvements and solutions.